THE SHARE: Change: +0.02 (+0.27%) / Price: 7.34 / Currency: SEK / 2021-04-16 17:09 (CEST)
  • Home
  • About
    • Introduction
    • Board of Directors
    • Management Team
    • Medical Advisors
  • Technology
    • EPR Effect
    • Publications
    • Patent
  • Portfolio
    • Pipeline
    • SpagoPix
    • Tumorad
  • Investor Relations
    • The Share
    • Analyst Coverage
    • Owners
    • Financial Reports
    • Corporate Governance
    • Financial Calendar
    • Shareholder’s Personal Data
    • Share Issue
  • Media
    • Presentations
    • Events
    • Image Bank
    • News
    • Press Releases
  • Contact
    • Contact us
    • Career

News

  • 8 Oct, 2020
    Spago Nanomedicals presentation på Erik Pensers Cancer Day
  • 5 Oct, 2020
    Spago Nanomedicals presentation på Erik Pensers Bolagsdagen
  • 18 Sep, 2020
    Dagens Börs intervju med VD Mats Hansen
  • 16 Sep, 2020
    Spago Nanomedicals presentation vid Aktiedagen digitalt
  • 24 Aug, 2020
    Spago Nanomedical utser produktkandidat i Tumorad®-projektet
  • 10 Jul, 2020
    Pandemins påverkan på bröstcancervården i Sverige
  • 22 Jun, 2020
    Spago Nanomedical presentation hos Aktietips
  • 19 May, 2020
    Nya prekliniska data för Tumorad® bekräftar ansamling i tumörer
  • 5 May, 2020
    Spago Nanomedicals presentation vid Aktiedagen digitalt
  • 24 Apr, 2020
    Spago Nanomedical AB (publ) offentliggör prospekt
  • 1
  • 2
  • 3
  • 4
  • …
  • 16
  • Previous
  • Next
Back
  • Presentations
  • Events
  • Image Bank
  • News
  • Press Releases

About Spago Nanomedical

Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise diagnosis and treatment of solid tumors.

Address

Spago Nanomedical AB
Scheelevägen 22
SE-223 63 Lund
Sweden

Contact

Phone: +46 46 811 88
LinkedIn

Member of:

Copyright © 2021 Spago Nanomedical AB. All Rights Reserved.
Design by Clavis Communications